CYTOR and colorectal carcinoma: LINC00152 contributes to the tumorigenesis, progression, and chemoresistance of CRC by inhibiting miR-139-5p, uncovering a novel ceRNA network of LINC00152/miR-139-5p/NOTCH1 in CRC cells.